{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:32:22Z","timestamp":1786361542953,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Megakaryocyte polyploidization is a specialized process essential for platelet production, orchestrated by tightly regulated transcriptional programs, cell-cycle control, and signaling pathways. Disruption of this process \u2013 characterized by incomplete endomitosis, low ploidy, and maturation arrest \u2013 contributes to leukemic transformation, particularly in acute megakaryoblastic leukemia and related myeloid malignancies. Aberrant polyploidization arises from transcription factor dysregulation, cell-cycle abnormalities, hyperactive proliferative signaling, microenvironmental alterations, and genomic instability. These defects collectively promote proliferation, differentiation arrest, and malignant expansion of megakaryocytic progenitors. Therapeutic strategies targeting these pathways, including modulation of transcription factors, restoration of endomitotic progression, inhibition of JAK\u2013STAT and RAS\/MAPK signaling, epigenetic reprogramming, and niche-directed interventions, offer promising avenues to suppress leukemic growth and restore normal maturation. Understanding aberrant polyploidization as a driver of leukemogenesis provides a framework for developing precision therapies in megakaryocytic leukemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004891","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:00:21Z","timestamp":1776794421000},"page":"3249-3253","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Aberrant polyploidization pathways in megakaryocytes as therapeutic targets in leukemia"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe"},{"name":"Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"R1-20260810","first-page":"3","article-title":"Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation","volume":"2","author":"Guo","year":"2015","journal-title":"Stem Cell Investig"},{"key":"R2-20260810","first-page":"212\u201319","article-title":"Megakaryopoiesis","volume":"47","author":"AE","year":"2010","journal-title":"Semin Hematol"},{"key":"R3-20260810","doi-asserted-by":"crossref","first-page":"707\u201316","DOI":"10.1080\/09537104.2019.1667497","article-title":"Megakaryocyte polyploidization: role in platelet production","volume":"31","author":"Vainchenker","year":"2020","journal-title":"Platelets"},{"key":"R4-20260810","doi-asserted-by":"crossref","first-page":"1\u20135","DOI":"10.1097\/MOH.0000000000000793","article-title":"The many faces of the megakaryocytes and their biological implications","volume":"31","author":"Guo","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"R5-20260810","doi-asserted-by":"crossref","first-page":"1\u20139","DOI":"10.1016\/j.exphem.2018.02.003","article-title":"Megakaryocyte ontogeny: clinical and molecular significance","volume":"61","author":"Elagib","year":"2018","journal-title":"Exp Hematol"},{"key":"R6-20260810","doi-asserted-by":"crossref","first-page":"843\u201362","DOI":"10.1631\/jzus.B2400127","article-title":"Endomitosis: a new cell fate in the cell cycle leading to polyploidy in megakaryocytes and hepatocytes","volume":"26","author":"Hua","year":"2025","journal-title":"J Zhejiang Univ Sci B"},{"key":"R7-20260810","doi-asserted-by":"crossref","first-page":"106\u201318","DOI":"10.1002\/iub.2177","article-title":"GATA1 mutations in red cell disorders","volume":"72","author":"Ling","year":"2020","journal-title":"IUBMB Life"},{"key":"R8-20260810","first-page":"76\u201392","article-title":"Down syndrome and leukemia: insights into leukemogenesis and translational targets","volume":"4","author":"Mateos","year":"2015","journal-title":"Transl Pediatr"},{"key":"R9-20260810","doi-asserted-by":"crossref","first-page":"691\u2013705","DOI":"10.1158\/2767-9764.CRC-23-0396","article-title":"Drug-resilient cancer cell phenotype is acquired via polyploidization associated with early stress response coupled to HIF2\u03b1 transcriptional regulation","volume":"4","author":"Carroll","year":"2024","journal-title":"Cancer Res Commun"},{"key":"R10-20260810","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/cells14211677","article-title":"Emerging roles of megakaryocytes in immune regulation and potential therapeutic prospects","volume":"14","author":"Kim","year":"2025","journal-title":"Cells"},{"key":"R11-20260810","doi-asserted-by":"crossref","first-page":"593\u2013604","DOI":"10.1111\/jth.12131","article-title":"Transcription factors in late megakaryopoiesis and related platelet disorders","volume":"11","author":"Tijssen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R12-20260810","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/ijms21061960","article-title":"The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer","volume":"21","author":"Ding","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R13-20260810","doi-asserted-by":"crossref","first-page":"770\u201378","DOI":"10.1080\/09537104.2021.1925102","article-title":"The thrombopoietin receptor: revisiting the master regulator of platelet production","volume":"32","author":"Hitchcock","year":"2021","journal-title":"Platelets"},{"key":"R14-20260810","doi-asserted-by":"crossref","first-page":"569\u201380","DOI":"10.1084\/jem.20040762","article-title":"Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis","volume":"200","author":"Tong","year":"2004","journal-title":"J Exp Med"},{"key":"R15-20260810","doi-asserted-by":"crossref","first-page":"926\u201337","DOI":"10.1002\/stem.1626","article-title":"Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin","volume":"32","author":"Malara","year":"2014","journal-title":"Stem Cells"},{"key":"R16-20260810","doi-asserted-by":"crossref","first-page":"483\u201391","DOI":"10.1182\/blood.2021012827","article-title":"The bone marrow niche from the inside out: how megakaryocytes are shaped by and shape hematopoiesis","volume":"139","author":"Stone","year":"2022","journal-title":"Blood"},{"key":"R17-20260810","doi-asserted-by":"crossref","first-page":"1430\u201339","DOI":"10.1111\/jth.14544","article-title":"New insights into cytoskeletal remodeling during platelet production","volume":"17","author":"Ghalloussi","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R18-20260810","first-page":"2341\u201345","article-title":"Evidence for a cytoplasmic proplatelet promoting factor that triggers platelet production","volume":"109","author":"Je","year":"2024","journal-title":"Haematologica"},{"key":"R19-20260810","doi-asserted-by":"crossref","first-page":"2972\u201376","DOI":"10.3324\/haematol.2021.280499","article-title":"Structure-function analysis of the role of megakaryoblastic leukemia 1 in megakaryocyte polyploidization","volume":"107","author":"Reed","year":"2022","journal-title":"Haematologica"},{"key":"R20-20260810","doi-asserted-by":"crossref","first-page":"193\u201396","DOI":"10.1007\/s12288-020-01355-z","article-title":"Loss of normal polyploid spectrum as marker of clonality in acute megakaryoblastic leukemia evolving from pre-existing primary myelofibrosis","volume":"37","author":"Gupta","year":"2021","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R21-20260810","doi-asserted-by":"crossref","first-page":"397\u2013407","DOI":"10.1634\/stemcells.19-5-397","article-title":"Molecular and transcriptional regulation of megakaryocyte differentiation","volume":"19","author":"Shivdasani","year":"2001","journal-title":"Stem Cells"},{"key":"R22-20260810","doi-asserted-by":"crossref","first-page":"963\u201373","DOI":"10.1080\/15384101.2016.1152423","article-title":"Consequences of abnormal CDK activity in S phase","volume":"15","author":"Anda","year":"2016","journal-title":"Cell Cycle"},{"key":"R23-20260810","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R24-20260810","doi-asserted-by":"crossref","first-page":"1011\u201330","DOI":"10.1038\/s41375-025-02569-8","article-title":"Malignant JAK-signaling: at the interface of inflammation and malignant transformation","volume":"39","author":"Perner","year":"2025","journal-title":"Leukemia"},{"key":"R25-20260810","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.3390\/ijms22147682","article-title":"The role of PI3K\/AKT and MAPK signaling pathways in erythropoietin signalization","volume":"22","author":"T\u00f3thov\u00e1","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R26-20260810","doi-asserted-by":"crossref","first-page":"1410637","DOI":"10.3389\/fcell.2024.1410637","article-title":"Polyploid giant cancer cells: origin, possible pathways of formation, characteristics, and mechanisms of regulation","volume":"12","author":"Liu","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"R27-20260810","doi-asserted-by":"crossref","first-page":"64\u201392","DOI":"10.1038\/s44321-023-00006-w","article-title":"Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression","volume":"16","author":"Molina","year":"2024","journal-title":"EMBO Mol Med"},{"key":"R28-20260810","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1017\/S1462399411002043","article-title":"Normal and malignant megakaryopoiesis","volume":"13","author":"Wen","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"R29-20260810","doi-asserted-by":"crossref","first-page":"3125\u201337","DOI":"10.3324\/haematol.2023.284951","article-title":"Epigenetic regulation of megakaryopoiesis and platelet formation","volume":"109","author":"Xu","year":"2024","journal-title":"Haematologica"},{"key":"R30-20260810","doi-asserted-by":"crossref","first-page":"271\u201380","DOI":"10.1615\/CritRevEukarGeneExpr.v17.i4.20","article-title":"Regulation of RUNX1 transcriptional function by GATA-1","volume":"17","author":"Elagib","year":"2007","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"R31-20260810","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/mmr.2024.13231","article-title":"An intricate regulatory circuit between FLI1 and GATA1\/GATA2\/LDB1\/ERG dictates erythroid vs. megakaryocytic differentiation","volume":"29","author":"Wang","year":"2024","journal-title":"Mol Med Rep"},{"key":"R32-20260810","doi-asserted-by":"crossref","first-page":"106920","DOI":"10.1016\/j.leukres.2022.106920","article-title":"Targeting cyclin-dependent kinases 4\/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia","volume":"120","author":"Qi","year":"2022","journal-title":"Leuk Res"},{"key":"R33-20260810","doi-asserted-by":"crossref","first-page":"537\u201345","DOI":"10.1038\/onc.2014.14","article-title":"The aurora kinases in cell cycle and leukemia","volume":"34","author":"Goldenson","year":"2015","journal-title":"Oncogene"},{"key":"R34-20260810","doi-asserted-by":"crossref","first-page":"2104\u201315","DOI":"10.1182\/blood-2014-03-559815","article-title":"JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation","volume":"124","author":"Besancenot","year":"2014","journal-title":"Blood"},{"key":"R35-20260810","doi-asserted-by":"crossref","first-page":"476\u201390","DOI":"10.4252\/wjsc.v11.i8.476","article-title":"Bone marrow microenvironment: the guardian of leukemia stem cells","volume":"11","author":"Houshmand","year":"2019","journal-title":"World J Stem Cells"},{"key":"R36-20260810","doi-asserted-by":"crossref","first-page":"271\u201383","DOI":"10.1586\/ehm.11.30","article-title":"The bone marrow microenvironment and leukemia: biology and therapeutic targeting","volume":"4","author":"Sison","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"R37-20260810","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s40164-025-00726-4","article-title":"Emerging strategies in CAR-T cell therapy for acute myeloid leukemia: overcoming heterogeneity and improving safety through dual-antigen targeting","volume":"14","author":"Oca\u00f1a-Cara","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"R38-20260810","doi-asserted-by":"crossref","first-page":"490\u2013504","DOI":"10.21147\/j.issn.1000-9604.2025.04.02","article-title":"Strategic innovations: tackling challenges of immunotherapy in acute myeloid leukemia","volume":"37","author":"Lin","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"R39-20260810","doi-asserted-by":"crossref","first-page":"542\u201348","DOI":"10.1016\/j.htct.2023.09.2364","article-title":"Immunophenotypic markers for the evaluation of minimal\/measurable residual disease in acute megakaryoblastic leukemia","volume":"46","author":"Pinto","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"key":"R40-20260810","first-page":"100082","article-title":"Transparency in the Reporting of Artificial Intelligence \u2013 the TITAN Guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:00:40Z","timestamp":1786359640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004891","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"2025-12-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}